Search Results - "TONG, Weida"

Refine Results
  1. 1

    DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans by Chen, Minjun, Suzuki, Ayako, Thakkar, Shraddha, Yu, Ke, Hu, Chuchu, Tong, Weida

    Published in Drug discovery today (01-04-2016)
    “…•DILIrank contains the largest number of drugs (N=1036) ranked by their risk for causing DILI.•The existing drug labeling-based DILI annotation was enhanced by…”
    Get full text
    Journal Article
  2. 2

    Development of Decision Forest Models for Prediction of Drug-Induced Liver Injury in Humans Using A Large Set of FDA-approved Drugs by Hong, Huixiao, Thakkar, Shraddha, Chen, Minjun, Tong, Weida

    Published in Scientific reports (11-12-2017)
    “…Drug-induced liver injury (DILI) presents a significant challenge to drug development and regulatory science. The FDA’s Liver Toxicity Knowledge Base (LTKB)…”
    Get full text
    Journal Article
  3. 3

    Persistent Organic Pollutants in Food: Contamination Sources, Health Effects and Detection Methods by Guo, Wenjing, Pan, Bohu, Sakkiah, Sugunadevi, Yavas, Gokhan, Ge, Weigong, Zou, Wen, Tong, Weida, Hong, Huixiao

    “…Persistent organic pollutants (POPs) present in foods have been a major concern for food safety due to their persistence and toxic effects. To ensure food…”
    Get full text
    Journal Article
  4. 4

    A Model to predict severity of drug‐induced liver injury in humans by Chen, Minjun, Borlak, Jürgen, Tong, Weida

    Published in Hepatology (Baltimore, Md.) (01-09-2016)
    “…Drug‐induced liver injury (DILI) is a major public health concern, and improving its prediction remains an unmet challenge. Recently, we reported the Rule‐of‐2…”
    Get full text
    Journal Article
  5. 5

    A generative adversarial network model alternative to animal studies for clinical pathology assessment by Chen, Xi, Roberts, Ruth, Liu, Zhichao, Tong, Weida

    Published in Nature communications (06-11-2023)
    “…Animal studies are unavoidable in evaluating chemical and drug safety. Generative Adversarial Networks (GANs) can generate synthetic animal data by learning…”
    Get full text
    Journal Article
  6. 6

    Drug-induced liver injury severity and toxicity (DILIst): binary classification of 1279 drugs by human hepatotoxicity by Thakkar, Shraddha, Li, Ting, Liu, Zhichao, Wu, Leihong, Roberts, Ruth, Tong, Weida

    Published in Drug discovery today (01-01-2020)
    “…[Display omitted] •This drug list provides access to the largest number of drugs classified for human hepatotoxicity.•DILIst (DILI severity and toxicity) is…”
    Get full text
    Journal Article
  7. 7

    FDA-approved drug labeling for the study of drug-induced liver injury by Chen, Minjun, Vijay, Vikrant, Shi, Qiang, Liu, Zhichao, Fang, Hong, Tong, Weida

    Published in Drug discovery today (01-08-2011)
    “…Drug-induced liver injury (DILI) is a leading cause of drugs failing during clinical trials and being withdrawn from the market. Comparative analysis of drugs…”
    Get full text
    Journal Article
  8. 8

    A decade of toxicogenomic research and its contribution to toxicological science by Chen, Minjun, Zhang, Min, Borlak, Jürgen, Tong, Weida

    Published in Toxicological sciences (01-12-2012)
    “…Toxicogenomics enjoyed considerable attention as a ground-breaking addition to conventional toxicology assays at its inception. However, the pace at which…”
    Get full text
    Journal Article
  9. 9

    Five-Feature Model for Developing the Classifier for Synergistic vs. Antagonistic Drug Combinations Built by XGBoost by Ji, Xiangjun, Tong, Weida, Liu, Zhichao, Shi, Tieliu

    Published in Frontiers in genetics (09-07-2019)
    “…Combinatorial drug therapy can improve the therapeutic effect and reduce the corresponding adverse events. strategies to classify synergistic vs. antagonistic…”
    Get full text
    Journal Article
  10. 10

    Towards accurate and reliable resolution of structural variants for clinical diagnosis by Liu, Zhichao, Roberts, Ruth, Mercer, Timothy R, Xu, Joshua, Sedlazeck, Fritz J, Tong, Weida

    Published in Genome Biology (03-03-2022)
    “…Structural variants (SVs) are a major source of human genetic diversity and have been associated with different diseases and phenotypes. The detection of SVs…”
    Get full text
    Journal Article
  11. 11

    Computational drug repositioning for rare diseases in the era of precision medicine by Delavan, Brian, Roberts, Ruth, Huang, Ruili, Bao, Wenjun, Tong, Weida, Liu, Zhichao

    Published in Drug discovery today (01-02-2018)
    “…•Next-generation sequencing technology accelerates rare disease research.•Accumulated genomics information aids orphan drug development.•Novel drug…”
    Get full text
    Journal Article
  12. 12

    Application of dynamic topic models to toxicogenomics data by Lee, Mikyung, Liu, Zhichao, Huang, Ruili, Tong, Weida

    Published in BMC bioinformatics (06-10-2016)
    “…All biological processes are inherently dynamic. Biological systems evolve transiently or sustainably according to sequential time points after perturbation by…”
    Get full text
    Journal Article
  13. 13

    Best practice and reproducible science are required to advance artificial intelligence in real-world applications by Liu, Zhichao, Li, Ting, Connor, Skylar, Thakkar, Shraddha, Roberts, Ruth, Tong, Weida

    Published in Briefings in bioinformatics (18-07-2022)
    “…Abstract Drug-induced liver injury (DILI) is one of the most significant concerns in medical practice but yet it still cannot be fully recapitulated with…”
    Get full text
    Journal Article
  14. 14

    High daily dose and being a substrate of cytochrome P450 enzymes are two important predictors of drug-induced liver injury by Yu, Ke, Geng, Xingchao, Chen, Minjun, Zhang, Jie, Wang, Bingshun, Ilic, Katarina, Tong, Weida

    Published in Drug metabolism and disposition (01-04-2014)
    “…Drug-induced liver injury (DILI) is complicated and difficult to predict. It has been observed that drugs with extensive hepatic metabolism have a higher…”
    Get full text
    Journal Article
  15. 15

    The landscape of hepatobiliary adverse reactions across 53 herbal and dietary supplements reveals immune-mediated injury as a common cause of hepatitis by Zhu, Jieqiang, Chen, Minjun, Borlak, Jürgen, Tong, Weida

    Published in Archives of toxicology (2020)
    “…Recent evidence suggests herbal-induced liver injury (HILI) to account for 20% of cases among the U.S. Drug-Induced-Liver-Injury-Network. To define injury…”
    Get full text
    Journal Article
  16. 16

    Associations of Drug Lipophilicity and Extent of Metabolism with Drug-Induced Liver Injury by McEuen, Kristin, Borlak, Jürgen, Tong, Weida, Chen, Minjun

    “…Drug-induced liver injury (DILI), although rare, is a frequent cause of adverse drug reactions resulting in warnings and withdrawals of numerous medications…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Comparing SVM and ANN based Machine Learning Methods for Species Identification of Food Contaminating Beetles by Bisgin, Halil, Bera, Tanmay, Ding, Hongjian, Semey, Howard G., Wu, Leihong, Liu, Zhichao, Barnes, Amy E., Langley, Darryl A., Pava-Ripoll, Monica, Vyas, Himansu J., Tong, Weida, Xu, Joshua

    Published in Scientific reports (25-04-2018)
    “…Insect pests, such as pantry beetles, are often associated with food contaminations and public health risks. Machine learning has the potential to provide a…”
    Get full text
    Journal Article
  19. 19

    NeuroCORD: A Language Model to Facilitate COVID-19-Associated Neurological Disorder Studies by Wu, Leihong, Ali, Syed, Ali, Heather, Brock, Tyrone, Xu, Joshua, Tong, Weida

    “…COVID-19 can lead to multiple severe outcomes including neurological and psychological impacts. However, it is challenging to manually scan hundreds of…”
    Get full text
    Journal Article
  20. 20

    Machine Learning for Predicting Risk of Drug-Induced Autoimmune Diseases by Structural Alerts and Daily Dose by Wu, Yue, Zhu, Jieqiang, Fu, Peter, Tong, Weida, Hong, Huixiao, Chen, Minjun

    “…An effective approach for assessing a drug’s potential to induce autoimmune diseases (ADs) is needed in drug development. Here, we aim to develop a workflow to…”
    Get full text
    Journal Article